| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |